Home > Income Statement > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Consolidated Net Profit

    Back to Income Statement
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹118 Cr₹96 Cr₹39 Cr₹102 Cr₹97 Cr

What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?

The latest Consolidated Net Profit ratio of MOREPEN LABORATORIES is ₹118 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹118 Cr
Mar2024₹96 Cr
Mar2023₹39 Cr
Mar2022₹102 Cr
Mar2021₹97 Cr

How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹118 Cr
22.73
Mar2024 ₹96 Cr
148.64
Mar2023 ₹39 Cr
-61.97
Mar2022 ₹102 Cr
4.73
Mar2021 ₹97 Cr -

Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹2,193.1 Cr 2.1% 2.2% -38.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

2.1%

2.2%

-38.3%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses